glp 1 meds As Interest in GLP-1 Drugs Spikes, Employers Weigh the Costs, Benefits What are GLP-1 medications and

Heres what you need to know about the new research published by The BMJ: How the study was designed Previous studies have suggested that the drugs known as GLP-1s, or glucagon-like peptide-1 receptor agonists, could reduce addictions by targeting the brains reward pathways

Waseem S, Moshiree B, Draganov PV

Used since 2005 primarily for people with type 2 diabetes, GLP-1 RAs have been very effective at improving markers like Hemoglobin A1c (HbA1c)

Glucagon-like peptide 1 (GLP1) receptor (GLP1R) agonists reduce body weight, glycaemia, blood pressure, postprandial lipaemia and inflammation actions that could contribute to the reduction of cardiovascular events

Another milestone in the evolution of GLP-1-based diabetes therapies